Jilin Joinature Polymer (SH:688716)2025-10-30 08:30Financial Performance - The company's operating revenue for Q3 2025 was ¥75,748,830.82, representing a year-on-year increase of 28.04%[3]. - The total profit for the period decreased by 61.06% to ¥5,375,122.06, while the net profit attributable to shareholders fell by 72.43% to ¥3,400,007.56[3][7]. - The net profit excluding non-recurring gains and losses for the period was ¥1,496,328.53, a decrease of 54.58%[3][7]. - The total profit for the year-to-date period decreased by 58.90% to ¥13,477,974.50[3][7]. - Net profit for the first three quarters of 2025 was ¥10,426,941.04, a significant decrease of 65.0% from ¥29,851,649.60 in the same period of 2024[18]. - Operating profit for the first three quarters of 2025 was ¥13,872,772.51, down 57.9% from ¥32,927,204.45 in 2024[18]. Cash Flow - The net cash flow from operating activities was negative at -¥40,179,573.53, a decline of 412.09% compared to the same period last year[3][8]. - Cash flow from operating activities for the first three quarters of 2025 was negative at -¥56,667,190.81, compared to a positive cash flow of ¥16,904,544.44 in 2024[22]. - The net cash flow from investing activities was -$94.58 million, a decrease from -$123.85 million year-over-year[23]. - The total cash inflow from financing activities was $49.31 million, compared to $59.27 million in the previous period[23]. - The net cash flow from financing activities was $24.23 million, down from $34.90 million year-over-year[23]. - The net increase in cash and cash equivalents was -$127.02 million, compared to -$72.05 million in the previous period[23]. - The ending balance of cash and cash equivalents was $425.08 million, down from $543.82 million year-over-year[23]. Research and Development - Research and development (R&D) expenses totaled ¥13,894,330.78, an increase of 87.07%, accounting for 18.34% of operating revenue, up 46.14 percentage points[4][8]. - The company emphasized its commitment to increasing R&D investment to support future growth and project development[7]. - Research and development expenses increased to ¥29,434,542.91 in 2025, compared to ¥21,097,214.47 in 2024, marking an increase of 39.5%[18]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,354,986,538.47, showing a slight increase of 0.037% from the previous year[4]. - Total current assets as of September 30, 2025, amount to ¥901,108,555.51, a decrease from ¥988,891,466.09 as of December 31, 2024[13]. - Total liabilities as of September 30, 2025, are ¥110,543,575.37, down from ¥121,308,317.65[14]. - Total liabilities as of the end of the reporting period were ¥172,405,620.57, a decrease from ¥182,330,870.90 in the previous year[15]. - Total equity attributable to shareholders increased to ¥1,182,580,917.90 from ¥1,172,153,976.86, reflecting a growth of 0.4%[15]. - Long-term assets increased to ¥453,877,982.96 from ¥365,593,381.67[14]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 17,036[10]. - The largest shareholder, Xie Huaijie, holds 36,928,382 shares, accounting for 30.35% of total shares[10]. - The company has no significant changes in major shareholders due to margin trading activities[11]. Other Information - The company has not reported any significant new strategies or product developments during the reporting period[12]. - There are no applicable audit opinions for the quarterly financial statements[12]. - The company reported a basic earnings per share of ¥0.03, down 70.00% compared to the same period last year[3][8]. - The company reported a basic earnings per share of ¥0.09 for the first three quarters of 2025, down from ¥0.25 in 2024[19].